Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Effect of a Multifaceted Quality Improvement Intervention on the Prescription of Evidence-Based Treatment in Patients at High Cardiovascular Risk in Brazil: The BRIDGE Cardiovascular Prevention Cluster Randomized Clinical Trial.

Machline-Carrion MJ, Soares RM, Damiani LP, Campos VB, Sampaio B, Fonseca FH, Izar MC, Amodeo C, Pontes-Neto OM, Santos JY, Gomes SPDC, Saraiva JFK, Ramacciotti E, Barros E Silva PGM, Lopes RD, Brandão da Silva N, Guimarães HP, Piegas L, Stein AT, Berwanger O; BRIDGE Cardiovascular Prevention Investigators.

JAMA Cardiol. 2019 Apr 3. doi: 10.1001/jamacardio.2019.0649. [Epub ahead of print]

PMID:
30942842
2.

Beneficial Effects of Green Banana Biomass Consumption in Patients with Pre-diabetes and Type 2 Diabetes: a Randomized Controlled Trial.

Costa ES, França CN, Fonseca FAH, Kato JT, Bianco HT, Freitas TT, Fonseca HAR, Neto AMF, Izar MC.

Br J Nutr. 2019 Mar 19:1-38. doi: 10.1017/S0007114519000576. [Epub ahead of print]

PMID:
30887937
3.

Regional QT Interval Dispersion as an Early Predictor of Reperfusion in Patients with Acute Myocardial Infarction after Fibrinolytic Therapy.

Dotta G, Fonseca FAH, Izar MCO, Souza MT, Moreira FT, Pinheiro LFM, Barbosa AHP, Caixeta AM, Póvoa RMS, Carvalho AC, Bianco HT.

Arq Bras Cardiol. 2019 Jan;112(1):20-29. doi: 10.5935/abc.20180239. Epub 2018 Dec 17. English, Portuguese.

4.

Capillary electrophoresis with dual diode array detection and tandem mass spectrometry to access cardiovascular biomarkers candidates in human urine: Trimethylamine-N-Oxide and l-carnitine.

Cieslarova Z, Magaldi M, Barros LA, do Lago CL, Oliveira DR, Fonseca FAH, Izar MC, Lopes AS, Tavares MFM, Klassen A.

J Chromatogr A. 2019 Jan 4;1583:136-142. doi: 10.1016/j.chroma.2018.10.005. Epub 2018 Nov 2.

PMID:
30509618
5.

Rare Presentation of Dercum's Disease in a Child with Abnormalities in Lipoprotein Metabolism.

Izar MCO, Fonseca HARD, França CN, Machado VA, Ferreira CEDS, Fonseca FAH.

Arq Bras Cardiol. 2018 Nov;111(5):755-757. doi: 10.5935/abc.20180191. English, Portuguese. No abstract available.

6.

Counterpoint: Flexibilization of Fasting for Laboratory Determination of the Lipid Profile in Brazil: Science or Convenience?

Izar MCO.

Arq Bras Cardiol. 2018 Nov;111(5):750-752. doi: 10.5935/abc.20180192. English, Portuguese. No abstract available.

7.

Rationale and design for a cluster randomized quality-improvement trial to increase the uptake of evidence-based therapies for patients at high cardiovascular risk: The BRIDGE-Cardiovascular Prevention trial.

Machline-Carrion MJ, Soares RM, Damiani LP, Campos VB, Sampaio B, Yamashita J, Fonseca FH, Izar MC, Amodeo C, Pontes-Neto OM, de Melo Barros PG, Lopes RD, Brandão da Silva N, Guimarães HP, Piegas L, Stein AT, Berwanger O.

Am Heart J. 2019 Jan;207:40-48. doi: 10.1016/j.ahj.2018.10.001. Epub 2018 Oct 17.

PMID:
30415082
8.

Predictors of Family Recruitment in a Program of Genetic Cascade Screening for Familial Hypercholesterolemia.

Izar MCO, Fonseca FAH.

Arq Bras Cardiol. 2018 Oct;111(4):585-586. doi: 10.5935/abc.20180193. English, Portuguese. No abstract available.

9.

Behavior of Blood Pressure Variables in Children and Adolescents with Duchenne Muscular Dystrophy.

Marui FRRH, Bianco HT, Bombig MTN, Palmeira NGF, Thalenberg JM, Povoa FF, Izar MCO, Fonseca FAH, Oliveira ASB, Povoa RMS.

Arq Bras Cardiol. 2018 Jun;110(6):551-557. doi: 10.5935/abc.20180085. English, Portuguese.

10.

Prevalence of Metabolic Syndrome and Framingham Risk Score in Vegetarian and Omnivorous Apparently Healthy Men.

Fonseca FAH, Izar MCO.

Arq Bras Cardiol. 2018 May;110(5):438-439. doi: 10.5935/abc.20180083. English, Portuguese. No abstract available.

11.

Diretriz brasileira baseada em evidências sobre prevenção de doenças cardiovasculares em pacientes com diabetes: posicionamento da Sociedade Brasileira de Diabetes (SBD), da Sociedade Brasileira de Cardiologia (SBC) e da Sociedade Brasileira de Endocrinologia e Metabologia (SBEM).

Faludi AA, Izar MCO, Saraiva JFK, Bianco HT, Chacra APM, Bertoluci MC, Moreira RO, Turatti LAA, Bertolami A, Sulzbach ML, Schaan BD, Valerio CM, Bertolami MC, Malachias MVB, Vencio S, Betti RTB, Fonseca FAH, Salles JEN, Hohl A.

Arq Bras Cardiol. 2017 Dec;109(6 Suppl 1):1-31. doi: 10.5935/abc.20170188. Portuguese. No abstract available.

12.

Association of Multiple Genetic Variants with the Extension and Severity of Coronary Artery Disease.

Fischer SCPM, Pinto SP, Lins LCDAS, Bianco HT, Monteiro CMC, Pinheiro LFM, Fonseca FAH, Izar MCO.

Arq Bras Cardiol. 2018 Jan;110(1):16-23. doi: 10.5935/abc.20170177. Epub 2018 Feb 1. English, Portuguese.

13.

Effects of four antiplatelet/statin combined strategies on immune and inflammatory responses in patients with acute myocardial infarction undergoing pharmacoinvasive strategy: Design and rationale of the B and T Types of Lymphocytes Evaluation in Acute Myocardial Infarction (BATTLE-AMI) study: study protocol for a randomized controlled trial.

Fonseca FAH, Izar MC, Maugeri IML, Berwanger O, Damiani LP, Pinto IM, Szarf G, França CN, Bianco HT, Moreira FT, Caixeta A, Alves CMR, Soriano Lopes A, Klassen A, Tavares MFM, Fonseca HA, Carvalho ACC; BATTLE-AMI Investigators.

Trials. 2017 Dec 19;18(1):601. doi: 10.1186/s13063-017-2361-1.

14.

Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2017.

Faludi AA, Izar MCO, Saraiva JFK, Chacra APM, Bianco HT, Afiune A Neto, Bertolami A, Pereira AC, Lottenberg AM, Sposito AC, Chagas ACP, Casella A Filho, Simão AF, Alencar AC Filho, Caramelli B, Magalhães CC, Negrão CE, Ferreira CEDS, Scherr C, Feio CMA, Kovacs C, Araújo DB, Magnoni D, Calderaro D, Gualandro DM, Mello EP Junior, Alexandre ERG, Sato EI, Moriguchi EH, Rached FH, Santos FCD, Cesena FHY, Fonseca FAH, Fonseca HARD, Xavier HT, Mota ICP, Giuliano ICB, Issa JS, Diament J, Pesquero JB, Santos JED, Faria JR Neto, Melo JX Filho, Kato JT, Torres KP, Bertolami MC, Assad MHV, Miname MH, Scartezini M, Forti NA, Coelho OR, Maranhão RC, Santos RDD Filho, Alves RJ, Cassani RL, Betti RTB, Carvalho T, Martinez TLDR, Giraldez VZR, Salgado W Filho.

Arq Bras Cardiol. 2017 Jul;109(2 Supl 1):1-76. doi: 10.5935/abc.20170121. Portuguese. No abstract available. Erratum in: Arq Bras Cardiol. 2017 Nov;109 (5):499.

15.

Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM).

Bertoluci MC, Moreira RO, Faludi A, Izar MC, Schaan BD, Valerio CM, Bertolami MC, Chacra AP, Malachias MVB, Vencio S, Saraiva JFK, Betti R, Turatti L, Fonseca FAH, Bianco HT, Sulzbach M, Bertolami A, Salles JEN, Hohl A, Trujilho F, Lima EG, Miname MH, Zanella MT, Lamounier R, Sá JR, Amodeo C, Pires AC, Santos RD.

Diabetol Metab Syndr. 2017 Jul 14;9:53. doi: 10.1186/s13098-017-0251-z. eCollection 2017. Review.

16.

Self-Reported High-Cholesterol Prevalence in the Brazilian Population: Analysis of the 2013 National Health Survey.

Lotufo PA, Santos RD, Sposito AC, Bertolami M, Rocha-Faria J Neto, Izar MC, Szwarcwald C, Prado RR, Stoppa SR, Malta DC, Bensenor IM.

Arq Bras Cardiol. 2017 May;108(5):411-416. doi: 10.5935/abc.20170055. English, Portuguese.

17.

Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease.

França CN, Izar MCO, Hortêncio MNS, do Amaral JB, Ferreira CES, Tuleta ID, Fonseca FAH.

Clin Sci (Lond). 2017 Jun 1;131(12):1215-1224. doi: 10.1042/CS20170009. Review.

PMID:
28566450
18.

Effects of Chronic Exercise on Endothelial Progenitor Cells and Microparticles in Professional Runners.

Bittencourt CRO, Izar MCO, França CN, Schwerz VL, Póvoa RMDS, Fonseca FAH.

Arq Bras Cardiol. 2017 Mar;108(3):212-216. doi: 10.5935/abc.20170022. Portuguese, English.

19.

Positioning about the Flexibility of Fasting for Lipid Profiling.

Scartezini M, Ferreira CEDS, Izar MCO, Bertoluci M, Vencio S, Campana GA, Sumita NM, Barcelos LF, Faludi AA, Santos RD, Malachias MVB, Aquino JL, Galoro CAO, Sabino C, Gurgel MHC, Turatti LAA, Hohl A, Martinez TLDR.

Arq Bras Cardiol. 2017 Mar;108(3):195-197. doi: 10.5935/abc.20170039. Portuguese, English. No abstract available.

20.

Electrocardiogram Performance in the Diagnosis of Left Ventricular Hypertrophy in Hypertensive Patients With Left Bundle Branch Block.

Burgos PF, Luna Filho B, Costa FA, Bombig MT, Souza D, Bianco HT, Oliveira Filho JA, Izar MC, Fonseca FA, Póvoa R.

Arq Bras Cardiol. 2017 Jan;108(1):47-52. doi: 10.5935/abc.20160187. Epub 2016 Dec 19. Portuguese, English.

21.

Effects of High-Intensity Training of Professional Runners on Myocardial Hypertrophy and Subclinical Atherosclerosis.

Bittencourt CR, Izar MC, Schwerz VL, Póvoa RM, Fonseca HA, Fonseca MI, Bianco HT, França CN, Ferreira CE, Fonseca FA.

PLoS One. 2016 Nov 11;11(11):e0166009. doi: 10.1371/journal.pone.0166009. eCollection 2016.

22.

Statin-associated muscle symptoms: position paper from the Luso-Latin American Consortium.

Sposito AC, Faria Neto JR, Carvalho LS, Lorenzatti A, Cafferata A, Elikir G, Esteban E, Morales Villegas EC, Bodanese LC, Alonso R, Ruiz AJ, Rocha VZ, Faludi AA, Xavier HT, Coelho OR, Assad MH, Izar MC, Santos RD, Fonseca FA, Mello E Silva A, Silva PM, Bertolami MC; ; on behalf of the Luso-Latin American Consortium on Statin-Associated Muscle Symptoms.

Curr Med Res Opin. 2017 Feb;33(2):239-251. doi: 10.1080/03007995.2016.1252740. Epub 2016 Dec 2. Review.

PMID:
27776432
23.

Challenges Facing the Use of Endothelial Progenitor Cells in Stem Cell Therapies.

Franca CN, Amaral JB, Tuleta ID, Siviero F, Ferreira CE, Izar MC, Fonseca FA.

Crit Rev Eukaryot Gene Expr. 2016;26(2):161-2. doi: 10.1615/CritRevEukaryotGeneExpr.2016016325. Review.

PMID:
27480778
24.

Corrigendum to 'The Brazilian Cardioprotective Nutritional Program to reduce events and risk factors in secondary prevention for cardiovascular disease: study protocol (The BALANCE Program Trial)' [American Heart Journal 171/1 (2016) 73-81].

Weber B, Bersch-Ferreira ÂC, Torreglosa CR, Ross-Fernandes MB, da Silva JT, Galante AP, de Sousa Lara E, Costa RP, Soares RM, Cavalcanti AB, Moriguchi EH, Bruscato NM, Kesties J, Vivian L, Schumacher M, de Carli W, Backes LM, Reolão BR, Rodrigues MP, Baldissera DM, Tres GS, Lisbôa HR, Bem JB, Reolão JB, Deucher KL, Cantarelli M, Lucion A, Rampazzo D, Bertoni V, Torres RS, Verríssimo AO, Guterres AS, Cardos AF, Coutinho DB, Negrão MG, Alencar MF, Pinho PM, Barbosa SN, Carvalho AP, Taboada MI, Pereira SA, Heyde RV, Nagano FE, Baumgartner R, Resende FP, Tabalipa R, Zanini AC, Machado MJ, Araujo H, Teixeira ML, Souza GC, Zuchinali P, Fracasso BM, Ulliam K, Schumacher M, Pierotto M, Hilário T, Carlos DM, Cordeiro CG, Carvalho DA, Gonçalves MS, Vasconcelos VB, Bosquetti R, Pagano R, Romano ML, Jardim CA, de Abreu BN, Marcadenti A, Schmitt AR, Tavares AM, Faria CC, Silva FM, Fink JS, El Kik RM, Prates CF, Vieira CS, Adorne EF, Magedanz EH, Chieza FL, Silva IS, Teixeira JM, Trescastro EP, Pellegrini LA, Pinto JC, Telles CT, Sousa AC, Almeida AS, Costa AA, Carmo JA, Silva JT, Alves LV, Sales SO, Ramos ME, Lucas MC, Damiani M, Cardoso PC, Ramos SS, Dantas CF, Lopes AG, Cabral AM, Lucena AC, Medeiros AL, Terceiro BB, Leda NM, Baía SR, Pinheiro JM, Cassiano AN, Melo AN, Cavalcanti AK, Souza CV, Queiroz DJ, Farias HN, Souza LC, Santos LS, Lima LR, Hoffmann MS, Ribeiro ÁS, Vasconcelos DF, Dutra ES, Ito MK, Neto JA, Santos AF, Sousa RM, Dias LP, Lima MT, Modanesi VG, Teixeira AF, Estrada LC, Modanesi PV, Gomes AB, Rocha BR, Teti C, David MM, Palácio BM, Junior DG, Faria ÉH, Oliveira MC, Uehara RM, Sasso S, Moreira AS, Cadinha AC, Pinto CW, Castilhos MP, Costa M, Kovacs C, Magnoni D, Silva Q, Germini MF, da Silva RA, Monteiro AS, Santos KG, Moreira P, Amparo FC, Paiva CC, Poloni S, Russo DS, Silveira IV, Moraes MA, Boklis M, Cardoso QI, Moreira AS, Damaceno AM, Santos EM, Dias GM, Pinho CP, Cavalcanti AC, Bezerra AS, Queiroga AV, Rodrigues IG, Leal TV, Sahade V, Amaral DA, Souza DS, Araújo GA, Curvello K, Heine M, Barretto MM, Reis NA, Vasconcelos SM, Vieira DC, Costa FA, Fontes JM, Neto JG, Navarro LN, Ferreira RC, Marinho PM, Abib RT, Longo A, Bertoldi EG, Ferreira LS, Borges LR, Azevedo NA, Martins CM, Kato JT, Izar MC, Asoo MT, de Capitani MD, Machado VA, Fonzar WT, Pinto SL, Silva KC, Gratão LH, Machado SD, de Oliveira SR, Bressan J, Caldas AP, Lima HC, Hermsdorff HH, Saldanha TM, Priore SE, Feres NH, de Queiroz Neves A, Cheim LM, Silva NF, Reis SR, Penafort AM, de Queirós AP, Farias GM, de Los Santos ML, Ambrozio CL, Camejo CN, Dos Santos CP, Schirmann GS, Boemo JL, Oliveira RE, Lima SM, Bortolini VM, Matos CH, Barretta C, Specht CM, de Souza SR, Arruda CS, Rodrigues PA, Berwanger O.

Am Heart J. 2016 May;175:202-203. doi: 10.1016/j.ahj.2016.04.012. No abstract available.

PMID:
27179741
25.

High-Sensitivity C-Reactive Protein and Cardiovascular Disease Across Countries and Ethnicities.

Fonseca FA, Izar MC.

Clinics (Sao Paulo). 2016 Apr;71(4):235-42. doi: 10.6061/clinics/2016(04)11. Review.

26.

Non-linear Optical Responses of Low-Density Lipoprotein are Associated with Intima-Media Thickness of Carotid Artery in Athletes.

Fonseca HA, Bittencourt CR, Fonseca FA, Monteiro AM, Santos PR, Camargo L, Costa LA, Murad A, Gidlund M, Figueiredo-Neto AM, Izar MC.

Cell Biochem Biophys. 2016 Jun;74(2):253-62. doi: 10.1007/s12013-016-0720-2. Epub 2016 Apr 28.

PMID:
27126056
27.

The Brazilian Cardioprotective Nutritional Program to reduce events and risk factors in secondary prevention for cardiovascular disease: study protocol (The BALANCE Program Trial).

Weber B, Bersch-Ferreira ÂC, Torreglosa CR, Ross-Fernandes MB, da Silva JT, Galante AP, Lara Ede S, Costa RP, Soares RM, Cavalcanti AB, Moriguchi EH, Bruscato NM, Kesties, Vivian L, Schumacher M, de Carli W, Backes LM, Reolão BR, Rodrigues MP, Baldissera DM, Tres GS, Lisbôa HR, Bem JB, Reolão JB, Deucher KL, Cantarelli M, Lucion A, Rampazzo D, Bertoni V, Torres RS, Verríssimo AO, Guterres AS, Cardos AF, Coutinho DB, Negrão MG, Alencar MF, Pinho PM, Barbosa SN, Carvalho AP, Taboada MI, Pereira SA, Heyde RV, Nagano FE, Baumgartner R, Resende FP, Tabalipa R, Zanini AC, Machado MJ, Araujo H, Teixeira ML, Souza GC, Zuchinali P, Fracasso BM, Ulliam K, Schumacher M, Pierotto M, Hilário T, Carlos DM, Cordeiro CG, Carvalho DA, Gonçalves MS, Vasconcelos VB, Bosquetti R, Pagano R, Romano ML, Jardim CA, de Abreu BN, Marcadenti A, Schmitt AR, Tavares AM, Faria CC, Silva FM, Fink JS, El Kik RM, Prates CF, Vieira CS, Adorne EF, Magedanz EH, Chieza FL, Silva IS, Teixeira JM, Trescastro EP, Pellegrini LA, Pinto JC, Telles CT, Sousa AC, Almeida AS, Costa AA, Carmo JA, Silva JT, Alves LV, Sales SO, Ramos ME, Lucas MC, Damiani M, Cardoso PC, Ramos SS, Dantas CF, Lopes AG, Cabral AM, Lucena AC, Medeiros AL, Terceiro BB, Leda NM, Baía SR, Pinheiro JM, Cassiano AN, Melo AN, Cavalcanti AK, Souza CV, Queiroz DJ, Farias HN, Souza LC, Santos LS, Lima LR, Hoffmann MS, Ribeiro ÁS, Vasconcelos DF, Dutra ES, Ito MK, Neto JA, Santos AF, Sousa RM, Dias LP, Lima MT, Modanesi VG, Teixeira AF, Estrada LC, Modanesi PV, Gomes AB, Rocha BR, Teti C, David MM, Palácio BM, Junior DG, Faria ÉH, Oliveira MC, Uehara RM, Sasso S, Moreira AS, Cadinha AC, Pinto CW, Castilhos MP, Costa M, Kovacs C, Magnoni D, Silva Q, Germini MF, da Silva RA, Monteiro AS, dos Santos KG, Moreira P, Amparo FC, Paiva CC, Poloni S, Russo DS, Silveira IV, Moraes MA, Boklis M, Cardoso QI, Moreira AS, Damaceno AM, Santos EM, Dias GM, Pinho CP, Cavalcanti AC, Bezerra AS, Queiroga AV, Rodrigues IG, Leal TV, Sahade V, Amaral DA, Souza DS, Araújo GA, Curvello K, Heine M, Barretto MM, Reis NA, Vasconcelos SM, Vieira DC, Costa FA, Fontes JM, Neto JG, Navarro LN, Ferreira RC, Marinho PM, Abib RT, Longo A, Bertoldi EG, Ferreira LS, Borges LR, Azevedo NA, Martins CM, Kato JT, Izar MC, Asoo MT, de Capitani MD, Machado VA, Fonzar WT, Pinto SL, Silva KC, Gratão LH, Machado SD, de Oliveira SR, Bressan J, Caldas AP, Lima HC, Hermsdorff HH, Saldanha TM, Priore SE, Feres NH, Neves Ade Q, Cheim LM, Silva NF, Reis SR, Penafort AM, de Queirós AP, Farias GM, de los Santos ML, Ambrozio CL, Camejo CN, dos Santos CP, Schirmann GS, Boemo JL, Oliveira RE, Lima SM, Bortolini VM, Matos CH, Barretta C, Specht CM, de Souza SR, Arruda CS, Rodrigues PA, Berwanger O.

Am Heart J. 2016 Jan;171(1):73-81.e1-2. doi: 10.1016/j.ahj.2015.08.010. Epub 2015 Aug 15.

PMID:
26699603
28.

Antihypertensive therapy increases natural immunity response in hypertensive patients.

Fonseca HA, Fonseca FA, Lins LC, Monteiro AM, Bianco HT, Brandão SA, Povoa RM, Juliano L, Figueiredo-Neto AM, Boschcov P, Gidlund M, Izar MC.

Life Sci. 2015 Dec 15;143:124-30. doi: 10.1016/j.lfs.2015.10.030. Epub 2015 Oct 26.

PMID:
26514303
29.

Additive effects of plant sterols supplementation in addition to different lipid-lowering regimens.

Malina DM, Fonseca FA, Barbosa SA, Kasmas SH, Machado VA, França CN, Borges NC, Moreno RA, Izar MC.

J Clin Lipidol. 2015 Jul-Aug;9(4):542-52. doi: 10.1016/j.jacl.2015.04.003. Epub 2015 Apr 25.

PMID:
26228672
30.

Plant sterol supplementation on top of lipid-lowering therapies in familial hypercholesterolemia.

Machado VA, Fonseca FA, Fonseca HA, Malina DT, Fonzar WT, Barbosa SA, Santana JM, Izar MC.

Int J Cardiol. 2015 Apr 1;184:570-2. doi: 10.1016/j.ijcard.2015.03.063. Epub 2015 Mar 4. No abstract available.

PMID:
25767019
31.

Microparticles as potential biomarkers of cardiovascular disease.

França CN, Izar MC, Amaral JB, Tegani DM, Fonseca FA.

Arq Bras Cardiol. 2015 Feb;104(2):169-74. doi: 10.5935/abc.20140210. Epub 2015 Jan 27. Review. English, Portuguese.

32.

High-intensity statin monotherapy versus moderate-intensity statin plus ezetimibe therapy: effects on vascular biomarkers.

Ferreira CE, França CN, Izar MC, Camargo LM, Roman RM, Fonseca FA.

Int J Cardiol. 2015 Feb 1;180:78-9. doi: 10.1016/j.ijcard.2014.11.177. Epub 2014 Nov 26. No abstract available.

PMID:
25438220
33.

Left ventricular hypertrophy and QTc dispersion are predictors of long-term mortality in subjects with type 2 diabetes.

Bianco HT, Izar MC, Póvoa RM, Bombig MT, Fonseca HA, Helfenstein T, Ferreira CE, Nicolau JC, Neto AA, Feio CM, Cerci MS, Fonseca FA.

Int J Cardiol. 2014 Oct 20;176(3):1170-2. doi: 10.1016/j.ijcard.2014.07.251. Epub 2014 Aug 12. No abstract available.

PMID:
25129285
34.

Relevance of target-organ lesions as predictors of mortality in patients with diabetes mellitus.

Bianco HT, Izar MC, Fonseca HA, Póvoa RM, Saraiva JF, Forti A, Jardim PC, Introcaso L, Yugar-Toledo J, Xavier HT, Faludi AA, Fonseca FA.

Arq Bras Cardiol. 2014 Oct;103(4):272-81. Epub 2014 Aug 1. English, Portuguese.

35.

Effects of ezetimibe on endothelial progenitor cells and microparticles in high-risk patients.

Lins LC, França CN, Fonseca FA, Barbosa SP, Matos LN, Aguirre AC, Bianco HT, do Amaral JB, Izar MC.

Cell Biochem Biophys. 2014 Sep;70(1):687-96. doi: 10.1007/s12013-014-9973-9.

PMID:
24777811
36.

Effects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy.

Camargo LM, França CN, Izar MC, Bianco HT, Lins LS, Barbosa SP, Pinheiro LF, Fonseca FA.

Braz J Med Biol Res. 2014 May;47(5):432-7. Epub 2014 May 2.

37.

[I Brazilian Guidelines for cardiovascular prevention].

Simão AF, Precoma DB, Andrade JP, Correa FH, Saraiva JF, Oliveira GM, Murro AL, Campos A, Alessi A, Avezum A Jr, Achutti AC, Miguel AC, Sousa AC, Lotemberg AM, Lins AP, Falud AA, Brandão AA, Sanjuliani AF, Sbissa AS, Alencar FA, Herdy AH, Polanczyk CA, Lantieri CJ, Machado CA, Scherr C, Stoll C, Amodeo C, Araújo CG, Saraiva D, Moriguchi EH, Mesquita ET, Fonseca FA, Campos GP, Soares GP, Feitosa GS, Xavier HT, Castro I, Giuliano IC, Rivera IV, Guimaraes IC, Issa JS, Souza JR, Faria NJ, Cunha LB, Pellanda LC, Bortolotto LA, Bertolami MC, Miname MH, Gomes MA, Tambascia M, Malachias MV, Silva MA, Izar MC, Magalhães ME, Bacellar MS, Milani M, Wajngarten M, Ghorayeb N, Coelho OR, Villela PB, Jardim PC, Santos Filho RD, Stein R, Cassani RS, D'Avila RI, Ferreira RM, Barbosa RB, Povoa RM, Kaiser SE, Ismael SC, Carvalho T, Giraldez VZ, Coutinho W, Souza WK; Sociedade Brasileira de Cardiologia.

Arq Bras Cardiol. 2013 Dec;101(6 Suppl 2):1-63. doi: 10.5935/abc.2013S012. Portuguese. No abstract available. Erratum in: Arq Bras Cardiol. 2014 Apr;102(4):415. Cesena, F H Y [removed].

38.

Effects of two lipid lowering therapies on immune responses in hyperlipidemic subjects.

Moreira FT, Ramos SC, Monteiro AM, Helfenstein T, Gidlund M, Damasceno NR, Neto AM, Izar MC, Fonseca FA.

Life Sci. 2014 Mar 11;98(2):83-7. doi: 10.1016/j.lfs.2014.01.001. Epub 2014 Jan 18.

PMID:
24447629
39.

[V Brazilian Guidelines on Dyslipidemias and Prevention of Atherosclerosis].

Xavier HT, Izar MC, Faria Neto JR, Assad MH, Rocha VZ, Sposito AC, Fonseca FA, dos Santos JE, Santos RD, Bertolami MC, Faludi AA, Martinez TL, Diament J, Guimarães A, Forti NA, Moriguchi E, Chagas AC, Coelho OR, Ramires JA.

Arq Bras Cardiol. 2013 Oct;101(4 Suppl 1):1-20. doi: 10.5935/abc.2013S010. Portuguese. No abstract available.

40.

I Brazilian position statement on arterial hypertension and diabetes mellitus.

Departament of Arterial Hypertension of Brazilian Society of Cardiology, Alessi A, Bonfim AV, Brandão AA, Feitosa A, Amodeo C, Alves CR, Brasil DP, Souza Ddo S, Barbosa E, Consolim-Colombo FM, Borelli F, Fonseca FH, Lopes HF, Chaves H, Bortolotto LA, Martin LC, Scala LC, Mota-Gomes MA, Malachias MV, Izar MC, Fonseca MI, Neves MF, Morais NS, Passarelli O Jr, Jardim PC, Toscano PR, Miranda RD, Franco R, Betti RT, Pedrosa RP, Povoa R, Carneiro SB, Jardim T, Barroso WK.

Arq Bras Cardiol. 2013 Jun;100(6):491-501. doi: 10.5935/abc.20130123. English, Portuguese. No abstract available.

41.

[First guidelines on fat consumption and cardiovascular health].

Santos RD, Gagliardi AC, Xavier HT, Magnoni CD, Cassani R, Lottenberg AM; Sociedade Brasileira de Cardiologia, Arpadi Faludi A, Geloneze B, Scherr C, Kovacs C, Tomazzela C, Carla C, Barrera-Arellano D, Cintra D, Quintão E, Nakandakare ER, Fonseca FA, Pimentel I, Ernesto dos Santos J, Bertolami MC, Rogero M, Izar MC, Nakasato M, Teixeira Damasceno NR, Maranhão R, Cassani RS, Perim R, Ramos S; Sociedade Brasileira de Cardiologia.

Arq Bras Cardiol. 2013 Jan;100(1 Suppl 3):1-40. Portuguese. No abstract available.

42.

Obesity modulates the immune response to oxidized LDL in hypertensive patients.

Fonseca HA, Fonseca FA, Monteiro AM, Bianco HT, Boschcov P, Brandão SA, Juliano L, Gidlund M, Izar MC.

Cell Biochem Biophys. 2013;67(3):1451-60. doi: 10.1007/s12013-013-9585-9.

PMID:
23559274
43.

[First Brazilian Guidelines for Familial Hypercholesterolemia].

Santos RD, Gagliardi AC, Xavier HT, Casella Filho A, Araújo DB, Cesena FY, Alves RJ; Sociedade Brasileira de Cardiologia, Pereira AC, Lottemberg AM, Chacra AP, Faludi AA, Sposito AC, Ribeiro Filho FF, Helfenstein Fonseca FA, de Carlos Back Giuliano I, Catani LH, Bertolami MC, Hiroshi Miname M, Izar MC, Monte O, Maranhão RC, Martinez TL, Arruda Machado V, Zorzanelli Rocha V, Salgado Filho W; Sociedade Brasileira de Cardiologia.

Arq Bras Cardiol. 2012 Aug;99(2 Suppl 2):1-28. Portuguese. No abstract available. Erratum in: Arq Bras Cardiol. 2017 Jun;108(6):578.

44.

Effects of ezetimibe on markers of synthesis and absorption of cholesterol in high-risk patients with elevated C-reactive protein.

Barbosa SP, Lins LC, Fonseca FA, Matos LN, Aguirre AC, Bianco HT, Amaral JB, França CN, Santana JM, Izar MC.

Life Sci. 2013 May 2;92(14-16):845-51. doi: 10.1016/j.lfs.2013.02.018. Epub 2013 Mar 16.

45.

Common sources and composition of phytosterols and their estimated intake by the population in the city of São Paulo, Brazil.

Martins CM, Fonseca FA, Ballus CA, Figueiredo-Neto AM, Meinhart AD, de Godoy HT, Izar MC.

Nutrition. 2013 Jun;29(6):865-71. doi: 10.1016/j.nut.2012.12.017. Epub 2013 Feb 16.

PMID:
23422542
46.

Differences in synthesis and absorption of cholesterol of two effective lipid-lowering therapies.

Kasmas SH, Izar MC, França CN, Ramos SC, Moreira FT, Helfenstein T, Moreno RA, Borges NC, Figueiredo-Neto AM, Fonseca FA.

Braz J Med Biol Res. 2012 Nov;45(11):1095-101. Epub 2012 Jul 19.

47.

Pharmacokinetic interactions between clopidogrel and rosuvastatin: effects on vascular protection in subjects with coronary heart disease.

Pinheiro LF, França CN, Izar MC, Barbosa SP, Bianco HT, Kasmas SH, Mendes GD, Povoa RM, Fonseca FA.

Int J Cardiol. 2012 Jun 28;158(1):125-9. doi: 10.1016/j.ijcard.2012.04.051. Epub 2012 May 7. No abstract available.

48.

Adaptive immunity is related to coronary artery disease severity after acute coronary syndrome in subjects with metabolic syndrome.

Izar MC, Fonseca HA, Pinheiro LF, Monteiro CM, Póvoa RM, Monteiro AM, Figueiredo-Neto AM, Gidlund MA, Fonseca FA.

Diab Vasc Dis Res. 2013 Jan;10(1):32-9. doi: 10.1177/1479164112443374. Epub 2012 Apr 23.

PMID:
22529217
49.

Inflammatory environment and immune responses to oxidized LDL are linked to systolic and diastolic blood pressure levels in hypertensive subjects.

da Fonseca HA, Fonseca FA, Monteiro AM, Farias NC Jr, Bianco HT, Brandão SA, Póvoa RM, Gidlund M, Izar MC.

Int J Cardiol. 2012 May 17;157(1):131-3. doi: 10.1016/j.ijcard.2012.03.041. Epub 2012 Mar 28. No abstract available.

50.

Endothelial progenitor cell mobilization and platelet microparticle release are influenced by clopidogrel plasma levels in stable coronary artery disease.

França CN, Pinheiro LF, Izar MC, Brunialti MK, Salomão R, Bianco HT, Kasmas SH, Barbosa SP, de Nucci G, Fonseca FA.

Circ J. 2012;76(3):729-36. Epub 2011 Dec 28.

Supplemental Content

Support Center